Ventyx Biosciences Inc (VTYX) has a current Price-to-Book (P/B) ratio of 3.13. Compared to its 3-year average P/B ratio of 2.09, the current P/B ratio is approximately 50.12% higher. Relative to its 5-year average P/B ratio of 2.47, the current P/B ratio is about 26.54% higher. Ventyx Biosciences Inc (VTYX) has a Forward Free Cash Flow (FCF) yield of approximately -14.66%. Compared to its 3-year average FCF yield of -66.36%, the current FCF yield is approximately -77.91% lower. Relative to its 5-year average FCF yield of -46.32%, the current FCF yield is about -68.36% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for VTYX competitors is -28.95, providing a benchmark for relative valuation. Ventyx Biosciences Inc Corp (VTYX.O) exhibits a P/S ratio of 0.00, which is -100% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of VTYX increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of VTYX in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is VTYX currently overvalued or undervalued?

What is Ventyx Biosciences Inc (VTYX) fair value?

VTYX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Ventyx Biosciences Inc (VTYX) is between to according to relative valuation method.

How does VTYX's valuation metrics compare to the industry average?

The average P/S ratio for VTYX's competitors is -28.95, providing a benchmark for relative valuation. Ventyx Biosciences Inc Corp (VTYX) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

What is the current P/B ratio for Ventyx Biosciences Inc (VTYX) as of Mar 02 2026?

As of Mar 02 2026, Ventyx Biosciences Inc (VTYX) has a P/B ratio of 3.13. This indicates that the market values VTYX at 3.13 times its book value.

What is the current FCF Yield for Ventyx Biosciences Inc (VTYX) as of Mar 02 2026?

As of Mar 02 2026, Ventyx Biosciences Inc (VTYX) has a FCF Yield of -14.66%. This means that for every dollar of Ventyx Biosciences Inc's market capitalization, the company generates -14.66 cents in free cash flow.

What is the current Forward P/E ratio for Ventyx Biosciences Inc (VTYX) as of Mar 02 2026?

As of Mar 02 2026, Ventyx Biosciences Inc (VTYX) has a Forward P/E ratio of -5.51. This means the market is willing to pay $-5.51 for every dollar of Ventyx Biosciences Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Ventyx Biosciences Inc (VTYX) as of Mar 02 2026?

As of Mar 02 2026, Ventyx Biosciences Inc (VTYX) has a Forward P/S ratio of 0.00. This means the market is valuing VTYX at $0.00 for every dollar of expected revenue over the next 12 months.

VTYX Valuation